Location History:
- Nantes, FR (2018 - 2020)
- Coueron, FR (2023)
Company Filing History:
3 out of 6 
2 out of 141 
1 out of 12 
Years Active: 2018-2023
Title: Denis Cochonneau: Innovator in Cancer Therapeutics
Introduction
Denis Cochonneau is a notable inventor based in Nantes, France. He has made significant contributions to the field of cancer therapeutics, holding a total of 3 patents. His work focuses on innovative methods for targeting cancer stem cells and improving drug delivery systems.
Latest Patents
Cochonneau's latest patents include groundbreaking methods for utilizing antibodies against O-acetylated GD2 ganglioside. One patent discloses a method for delivering an anti-cancer agent into cells expressing the OAcGD2 ganglioside. Another patent outlines a new therapeutic and diagnostic strategy for cancer, involving an antibody that targets O-acetylated GD2 ganglioside for the treatment of cancer stem cells. This includes a pharmaceutical composition for treating cancer stem cells and methods for diagnosing and predicting treatment responses in patients.
Career Highlights
Throughout his career, Denis Cochonneau has worked with prominent organizations such as Ogd2 Pharma and Université de Nantes. His research has significantly advanced the understanding of cancer treatment and diagnostics.
Collaborations
Cochonneau has collaborated with esteemed colleagues, including Jean-Marc Le Doussal and Stephane Birkle. Their joint efforts have contributed to the development of innovative cancer therapies.
Conclusion
Denis Cochonneau's work exemplifies the impact of innovative thinking in the medical field, particularly in cancer treatment. His patents and collaborations highlight his commitment to advancing therapeutic strategies for cancer stem cells.